Contact this trialFirst, we need to learn more about you.
Checkpoint Inhibitor
Nivolumab + Ipilimumab for Melanoma
Recruiting1 awardPhase 2
Farmington, Connecticut
This trial is studying how well nivolumab works in treating patients with cancer. Researchers also want to find out what effects, good and bad, nivolumab has on patients.
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.